Holders over time
- HIMS
- ELV
| Quarter | HIMS | ELV |
|---|---|---|
| Q3 2020 | none listed holders, n.a. | 30 holders, $15.0bn |
| Q4 2020 | none listed holders, n.a. | 29 holders, $16.7bn |
| Q1 2021 | 3 holders, $73m | 25 holders, $18.6bn |
| Q2 2021 | 2 holders, $60m | 30 holders, $19.4bn |
| Q3 2021 | 1 holders, $28m | 26 holders, $18.5bn |
| Q4 2021 | 1 holders, $25m | 29 holders, $23.3bn |
| Q1 2022 | 1 holders, $17m | 31 holders, $23.9bn |
| Q2 2022 | 1 holders, $15m | 32 holders, $23.3bn |
| Q3 2022 | 3 holders, $21m | 34 holders, $22.6bn |
| Q4 2022 | 3 holders, $51m | 34 holders, $25.5bn |
| Q1 2023 | 7 holders, $91m | 39 holders, $22.5bn |
| Q2 2023 | 5 holders, $86m | 38 holders, $20.6bn |
| Q3 2023 | 4 holders, $56m | 34 holders, $19.8bn |
| Q4 2023 | 4 holders, $64m | 36 holders, $20.3bn |
| Q1 2024 | 8 holders, $242m | 35 holders, $21.3bn |
| Q2 2024 | 11 holders, $344m | 33 holders, $22.1bn |
| Q3 2024 | 13 holders, $313m | 30 holders, $20.2bn |
| Q4 2024 | 10 holders, $628m | 32 holders, $15.9bn |
| Q1 2025 | 8 holders, $738m | 28 holders, $17.1bn |
| Q2 2025 | 9 holders, $1.9bn | 27 holders, $14.8bn |
| Q3 2025 | 9 holders, $2.5bn | 27 holders, $12.7bn |
| Q4 2025 | 4 holders, $740m | 25 holders, $17.0bn |
| Q1 2026 | 6 holders, $68m | 26 holders, $13.6bn |
| Q2 2026 | 4 holders, $183m | 28 holders, $17.7bn |
Hims & Hers Health Inc
- Holders
- 13
- Reported value
- $313m
- Buyers
- 7
- Sellers
- 5
Breadth +2 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 30
- Reported value
- $20.2bn
- Buyers
- 16
- Sellers
- 16
Breadth 0 among 94 comparable managers.
Who holds both, Q3 2024
Both (8)
Arrowstreet Capital LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Man Group PLC, Two Sigma Investments LP, Verition Fund Management LLC, Voloridge Investment Management LLC
Only HIMS (5)
Farallon Capital Management LLC, Marshall Wace LLP, Oaktree Capital Management LP, Renaissance Technologies LLC, Tybourne Capital Management HK Ltd
Only ELV (22)
AllianceBernstein LP, AQR Capital Management LLC, Artisan Partners LP, Baillie Gifford & Co, Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Wellington Management Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.